HTA's are becoming a prerequisite for successful pricing & reimbursement. However, cross national variations in assessment, appraisal and decision making may hamper innovation and delay access. Societal, ethical and economic aspects are still national. However, at least the assessment of relative effectiveness has the potential of joint international collaboration.
pharmaLevers is helping clients to:
design (pre-scoping) and analyze HTA
get policy and payer's input for HTA
leverage positive HTA results in the market
train your team on HTA and outcome management